These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21752270)

  • 1. Living with myotonic dystrophy; what can be learned from couples? A qualitative study.
    Cup EH; Kinébanian A; Satink T; Pieterse AJ; Hendricks HT; Oostendorp RA; van der Wilt GJ; van Engelen BG
    BMC Neurol; 2011 Jul; 11():86. PubMed ID: 21752270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C; Meuleman S; Hellebrekers D; Kruitwagen-van Reenen E; Visser-Meily J
    J Neuromuscul Dis; 2018; 5(2):205-214. PubMed ID: 29865086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.
    LaDonna KA; Venance SL
    J Neurosci Nurs; 2015 Oct; 47(5):285-95. PubMed ID: 26348433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Case Study of Changes in Participation of Adults with Myotonic Dystrophy Type 1: Importance of Redesigning Accomplishment and Resilience.
    Raymond K; Gagnon C; Levasseur M
    J Neuromuscul Dis; 2022; 9(6):731-755. PubMed ID: 36214003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Qualitative Investigation of Health Care Professionals', Patients' and Partners' Views on Psychosocial Issues and Related Interventions for Couples Coping with Cancer.
    Regan T; Levesque JV; Lambert SD; Kelly B
    PLoS One; 2015; 10(7):e0133837. PubMed ID: 26222890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropsychological profile in patients with myotonic dystrophy type 1: a four-year follow-up study].
    Díaz-Leiva J; Cabada-Giadás T; Seijas-Gómez R; Jericó-Pascual I; López-Sala P; Iridoy-Zulet M
    Rev Neurol; 2020 Jun; 70(11):406-412. PubMed ID: 32436207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceived functioning and disability in adults with myotonic dystrophy type 1: a survey according to the International Classification Of Functioning, Disability and Health.
    Kierkegaard M; Harms-Ringdahl K; Widén Holmqvist L; Tollbäck A
    J Rehabil Med; 2009 Jun; 41(7):512-20. PubMed ID: 19543661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive Decline in Daily and Social Activities: A 9-year Longitudinal Study of Participation in Myotonic Dystrophy Type 1.
    Raymond K; Levasseur M; Mathieu J; Gagnon C
    Arch Phys Med Rehabil; 2019 Sep; 100(9):1629-1639. PubMed ID: 30831092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplastic nevi, cutaneous melanoma, and other skin neoplasms in patients with myotonic dystrophy type 1: a cross-sectional study.
    Zampetti A; Silvestri G; Manco S; Khamis K; Masciullo M; Bianchi ML; Damiani A; Santoro M; Linder D; Bewley A; Feliciani C
    J Am Acad Dermatol; 2015 Jan; 72(1):85-91. PubMed ID: 25440959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of participation in myotonic dystrophy: reliability of the LIFE-H.
    Gagnon C; Mathieu J; Noreau L
    Neuromuscul Disord; 2006 Apr; 16(4):262-8. PubMed ID: 16545567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
    Busolo D; Woodgate R
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of congenital and childhood myotonic dystrophy on quality of life: a qualitative study of associated symptoms.
    Johnson NE; Luebbe E; Eastwood E; Chin N; Moxley RT; Heatwole CR
    J Child Neurol; 2014 Jul; 29(7):983-6. PubMed ID: 23611887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
    Gutiérrez Gutiérrez G; Díaz-Manera J; Almendrote M; Azriel S; Eulalio Bárcena J; Cabezudo García P; Camacho Salas A; Casanova Rodríguez C; Cobo AM; Díaz Guardiola P; Fernández-Torrón R; Gallano Petit MP; García Pavía P; Gómez Gallego M; Gutiérrez Martínez AJ; Jericó I; Kapetanovic García S; López de Munaín Arregui A; Martorell L; Morís de la Tassa G; Moreno Zabaleta R; Muñoz-Blanco JL; Olivar Roldán J; Pascual Pascual SI; Peinado Peinado R; Pérez H; Poza Aldea JJ; Rabasa M; Ramos A; Rosado Bartolomé A; Rubio Pérez MÁ; Urtizberea JA; Zapata-Wainberg G; Gutiérrez-Rivas E
    Med Clin (Barc); 2019 Jul; 153(2):82.e1-82.e17. PubMed ID: 30685181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease.
    Gutiérrez Gutiérrez G; Díaz-Manera J; Almendrote M; Azriel S; Eulalio Bárcena J; Cabezudo García P; Camacho Salas A; Casanova Rodríguez C; Cobo AM; Díaz Guardiola P; Fernández-Torrón R; Gallano Petit MP; García Pavía P; Gómez Gallego M; Gutiérrez Martínez AJ; Jericó I; Kapetanovic García S; López de Munaín Arregui A; Martorell L; Morís de la Tassa G; Moreno Zabaleta R; Muñoz-Blanco JL; Olivar Roldán J; Pascual Pascual SI; Peinado Peinado R; Pérez H; Poza Aldea JJ; Rabasa M; Ramos A; Rosado Bartolomé A; Rubio Pérez MÁ; Urtizberea JA; Zapata-Wainberg G; Gutiérrez-Rivas E
    Neurologia (Engl Ed); 2020 Apr; 35(3):185-206. PubMed ID: 31003788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truths and misinformation: a qualitative exploration of myotonic dystrophy.
    LaDonna KA; Ghavanini AA; Venance SL
    Can J Neurol Sci; 2015 May; 42(3):187-94. PubMed ID: 25867706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the experience of myotonic dystrophy. Mixed method study.
    Geirdal AØ; Lund-Petersen I; Heiberg A
    J Genet Couns; 2015 Feb; 24(1):169-78. PubMed ID: 25123360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis.
    Russo V; Di Meo F; Rago A; Papa AA; Molino A; Mosella M; Politano L; Russo MG; Nigro G
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(7):1241-8. PubMed ID: 25912584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.